Research interests include Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, and Inflammatory Biomarkers in Disease Prognosis.
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair–deficient Metastatic Castration-resistant Prostate Cancer
European Urology Oncology2025cited by 8position: firstdoi
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment
Clinical Cancer Research2024cited by 5position: middledoi
Detection and localization of early- and late-stage cancers using platelet RNA